Does IXEKIZUMAB Cause Conjunctivitis? 59 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Conjunctivitis have been filed in association with IXEKIZUMAB (TALTZ). This represents 0.2% of all adverse event reports for IXEKIZUMAB.
59
Reports of Conjunctivitis with IXEKIZUMAB
0.2%
of all IXEKIZUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Conjunctivitis From IXEKIZUMAB?
Of the 59 reports, 1 (1.7%) required hospitalization.
Is Conjunctivitis Listed in the Official Label?
Yes, Conjunctivitis is listed as a known adverse reaction in the official FDA drug label for IXEKIZUMAB.
What Other Side Effects Does IXEKIZUMAB Cause?
Injection site pain (3,799)
Psoriasis (2,818)
Drug ineffective (2,759)
Injection site erythema (2,144)
Injection site reaction (1,701)
Injection site swelling (1,615)
Incorrect dose administered (1,032)
Covid-19 (861)
Product dose omission issue (832)
Therapy interrupted (796)
What Other Drugs Cause Conjunctivitis?
DUPILUMAB (5,270)
ADALIMUMAB (457)
METHOTREXATE (385)
ETANERCEPT (306)
PREDNISONE (250)
SECUKINUMAB (237)
RITUXIMAB (222)
SULFAMETHOXAZOLE\TRIMETHOPRIM (218)
INFLIXIMAB (212)
LAMOTRIGINE (199)
Which IXEKIZUMAB Alternatives Have Lower Conjunctivitis Risk?
IXEKIZUMAB vs JAKAFI
IXEKIZUMAB vs JANUMET
IXEKIZUMAB vs JANUVIA
IXEKIZUMAB vs JETREA
IXEKIZUMAB vs JUXTAPID